Upload
druprathnakarmddihpgdhm
View
218
Download
0
Embed Size (px)
Citation preview
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
1/31
PharmacodynamicsDr.U.P.Rathnakar
MD.DIH.PGDHM
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
2/31
Adverse Drug Effects
Any undesirable or unintended consequence of
drug administration
Any response to a drug that is noxious and
unintended and that occurs at doses used in man
for the prophylaxis, diagnosis, or therapy of
disease or for modification of physiological
function WHO
Adverse event: Any untoward event that occurs
during treatment not necessarily with causal
relation ship to treatment
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
3/31
Adverse Drug Reactions
[ADR]
Drugs used for favorable response
Unfortunately also produce ADR
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
4/31
ADR: Severity
Minor:
No tt required
Moderate: Requires change in tt, change of drug
Severe:
Potentially life threatening, permanent damage Lethal:
Directly or indirectly contributes to death
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
5/31
ADR
Type A[Augmented]
Extension of
pharmacological actions
Predictable Dose dependent
High incidence
Low mortality
Dose reduction
Eg. Blurring of vision &
dryness of mouth [atropine]
Hypoglycemia[Glipizide]
Type B [Bizarre]
Immunological/genetic
Not predictable
Qualitative[not dose dependent]
Low incidence
High mortality
Discontinue drug
Eg. Anaphylaxis due to
Penicillin , Hemolysis due to
primaquine
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
6/31
ADR
Type A[augmented]
Side effects:
Unwanted ,unavoidable pharmacodynamic effects at
therapeutic doses
Eg. Antihistaminics cause sedation Secondary effects:
Indirect consequence of primary action of a drug
Eg. Tetracyclines cause super infection
Toxic effects: Due to overdose or prolonged use
Eg. Respiratory failure by morphine
Coma by barbiturates
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
7/31
ADR
Type B[Bizarre]
Allergy/hypersensitivity
Idiosyncratic
Type C[Continuous use]
[dependence, organ
toxicity]
Type D[Delayed effect]
Mutagenicity,
carcinogenicity,
teratogenic effect Type E[End of use]
[withdrawal, HPA axis
suppression]
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
8/31
Intolerance
Low threshold to the action of drug
Eg. EPS with single dose of Metoclopromide
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
9/31
Idiosyncrasy
A genetically determined reaction
An unusual individual reaction to food or a drug
Eg. Barbiturates cause excitement and mental confusion
Chloramphenicol causes aplastic anemia
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
10/31
Drug allergy
(drug hypersensitivity)
Immunologically mediated reaction
Types of drug allergy
1. Anaphylactic- -Type I
2. Cytolytic- -Type II
3. Immune complex
mediated[Arthus]: -Type III
4. Delayed
hypersensitivity -Type IV
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
11/31
Type 1
Eg. Betalactam antimicrobial agents
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
12/31
Type 1
[Anaphylactic]Exposure to
drugEg.Penicillin
IgE ABFixed tomast cells
Re-exposure
AG+AB
Release of mediators:
Histamine, 5-HT, PGs,LTs, PAF
Anaphylactic shock:
Hypotension,
Bronchospasm, UrticariaEtc.
Treatment:Medical emergency
Inj.Adrenaline[1:1000]
0.3 to 0.5 ml i.m.
Inj.Hydrocortisone
100 mgi.v.Inj.Diphenhydramine
25mg i.v.
Oxygen
i.v. fluids
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
13/31
Type II[Cytotoxic]
Eg. Sulfa, thiazides, quinidinepuprura, hemolysis
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
14/31
Type II [Cytolytic]
Exposure to drug
Eg.Quinine
Drug+Tissue=AG
IgG, IgM- ABRe exposure
Tissue+AB
Complement
Cell destruction
Eg. Hemolysis
by Quinine,
Quinidine
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
15/31
Type III
AG+ABIgG
Complementfixation
Destructive inflammatory response
Eg. Serum sicknes [Fever,urticaria, joint pain,lymphadenopathy]
Penicillin,
SulfaNSAIDs
Deposited on vascular
endothelium
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
16/31
Type IV[cell mediated, delayed]
Eg.Contact dermatitis by metals, ointments
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
17/31
Type IV [Delayed]
Inflammatory responseDelayed by 2-3 days
Not AB related
Cell mediated
Eg. Contact dermatitis with LA creams
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
18/31
Photosensitivity[Pt. taking a drug develops reaction on body parts exposed to light]
Phototoxicity [hyperpigmentation[desquamation]
Sensitization of the skin by drugs
UV radiation Cutaneous reaction-Photosensitivity
Stopped when drug stopped
Photo allergy [eczematous, papular]
Persists even after drug withdrawal
Examples????
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
19/31
Carcinogenicity & mutagenicity
Ability of the drug to cause cancer and genetic
defects respectively
Eg. Tobacco, anticancer drugs
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
20/31
Iatrogenic diseases:
iatros = physician
(physician induced diseases):
ParkinsonismPhenothiazines Peptic ulcer Aspirin,corticosteroids
Hepatitis - Isoniazid
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
21/31
Drugs frequently cause allergic
reactions
Penicillins
Cephalosporin
Sulfonamides
Tetracyclines
Quinolones
Antitubercular drugs
Salicylates
Carbamazapine
ACE inhibitors
Local anesthetics
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
22/31
Teratogenicity
terataos = monster
Capacity of the drug to cause fetal abnormalities when
administered to pregnant mother
I. Pre-implantation: conception to 17 days-Abortion
ii.Organogenesis: 18-55 days-Deformities
iii.Growth and development: 56 days onwards
ThalidomidePhocomelia
CorticosteroidsCleft lip
TC- Discolouration of teeth, retarded bone growth
PREGNANCY
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
23/31
PREGNANCY
CATEGORIES
Category A [ANIMALS [-] Humans[-]-------------No riskStudies have failed to demonstrate a risk to the fetus
Category B [ANIMALS [-] Humans[Not known] [ANIMALS [+] Human[none] ---No evidence
of risk
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are
no studies in pregnant women.
Category C [ANIMALS [++] Humans[Not known] [Consider risk benefit before use]
Animal reproduction studies have shown an adverse effect on the fetus and there are no
adequate and well-controlled studies in humans, but potential benefits may warrant use of
the drug in pregnant women despite potential risks.
Category D [Humans risk ++] [Benefit may outweigh risk]There is positive evidence of human fetal risk - but potential benefits may warrant use of
the drug in pregnant women despite potential risks.
Category X [Abnormalities demonstrated] [Not to be used in pregnant women]
Studies in animals or humans have demonstrated fetal abnormalities and/or there is
positive evidence of human fetal risk based on adverse reaction data from investigational
or marketing experience and the risks involved in use of the drug in pregnant womenclearly outweigh potential benefits.
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
24/31
Organ toxicity
Hepatotoxicity: INH, Rifampicin
Nephrotoxicity: Aminoglycosides
Ototoxicity: Aminoglycosides, Frusemide
Ocular toxicity: Ethambutol, Chloroquine
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
25/31
Drug dependence
A state of
Psychological or physical dependence
Due to interaction - living organism+Drug
Characterized by behavioral and other responses Always includes a compulsion to take the drug continuously or
periodically
Psychological: Intense desire to take drug and immensesatisfaction later
Physical: Physiological equilibrium is maintained by drug
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
26/31
Poisoning
Poisons in small doses are the best medicines;
and useful medicines in too large doses are
poisonous
William Withering 1789
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
27/31
Poisoning
Large enough dose of a drug
Substance which endangers life
Accidental or suicidal
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
28/31
Poisoning
Principles of treatment
1.Resuscitation and maintenance of vital functions
Airway, BP, Body temp., Blood sugar
2. Termination of exposure
Fresh air, remove wet clothes, wash,
3. Prevention of absorption
Gastric lavage, Activated charcoal,
4. Hastening elimination
Diuresis, Altering urine pH, Hemodialysis
5. Antidotes if available
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
29/31
Prevention of adverse effects
Right dose, route, frequency
Previous history drug allergy and allergic
diseases
Rule out drug interactions
Correct technique of administration
TDM if appropriate
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
30/31
Clinical significance of ADR
Common-
3-5% of admissions
Increases duration of
stay
Initially reversible
Awareness-ADR or new
symptoms
Surgeries are avoided
[gynecomastia andspironolactone]
Reduce the no.of drugs
7/27/2019 Pharmacodynamics MBBS-Class 4.pptx
31/31
Pharmacovigilance
Actively look for adverse drug effects
Activities relating to detection, assessment, understanding and prevention
of adverse effects or any other drug related problem
Causality assessment1. Temporal relationship
2. Previous knowledge
3. Dechallenge
4. Rechallenge
Information collected by
Regional centers to
Zonal centers to
National centers to
Uppsala monitoring center (Sweden)
Definite, probable, possible or doubtful